InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,652.00
(
0.06%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,849.56
(
0.09%
)
Post# of 514
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

kld2

Send PM Follow Ignore
Followers 20
Posts 2007
Boards Moderated 0
Alias Born 10/27/2013

kld2

Re: None

Monday, 02/20/2017 6:21:44 AM

Monday, February 20, 2017 6:21:44 AM

Post# of 514
Anyone have any idea what the mc of immu would be if 132 is approved for both bladder and breast cancer? TNB seems a slam dunk, with BTD and good data. venBio estimated, if approved, Immnomedics should be valued at 1.5b. How about if bladder is approved (later on, of course)? Believe it is about a 500m market. Plus there is combo to think about.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up